Assignee
FORTIS THERAPEUTICS INC
US·3 granted patents·2 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
5 records- 0168US12144888B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 0267US2023035087A1Immunoconjugates targeting cd46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0365US11484604B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·0 cites·4 claims
- 0452US2024058464A1Combination therapy with for46 for cancerFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0544US12049511B2Engineered CD46-specific effector cells and uses thereof in the treatment of cancerFORTIS THERAPEUTICS INC·Filed 2017·Granted Jul 30, 2024·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when FORTIS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →